Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01731 |
| Species: | Homo sapiens |
| Position : | chr7:117504671-117505671 |
| Year: | 2022 |
| Title: | Epigenome editing of the CFTR-locus for treatment of Cystic Fibrosis |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 34049825 |
| MONDO: | |
| Tissue: | Lung |
| Tissue Ontology ID: | UBERON:0002048 |
| Cell Source: | UNCCF3T (??F508/??F508 HBE) |
| CVCL ID: | CVCL_0063 |
| Cell Type: | bronchial epithelial cell |
| Cell Ontology ID: | CL:0002591 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, RT-RT-qPCR, Western blot, Ussing Chamber Assay |
| Target gene : | CFTR |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01730 | chr7:117504671-117505671 | Embryonic Kidney | embryonic kidney cell | -- |